RA0813

antibody from Oursmab

Targeting: VEGFB VEGFL, VRF

Western blot (Supportive data in Antibodypedia)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0813

Provider

Oursmab

Product name

Reflocibart (Biosimilar Reference Antibody) (VEGFB)

Antibody type

Monoclonal

Description

Reflocibart is a humanized IgG4 kappa monoclonal antibody targeting vascular endothelial growth factor B (VEGF-B). It binds to and neutralizes VEGF-B, thereby inhibiting VEGF-B-mediated signaling pathways involved in pathological angiogenesis, vascular leakage, and inflammatory responses. It is being investigated for the treatment of retinal vascular diseases such as diabetic macular edema and neovascular age-related macular degeneration (AMD).

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Reflocibart (Biosimilar Reference Antibody) (VEGFB)-RA0813-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.